Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.98 billion.
Market Cap
1.12T
Revenue
110.98B
Profits
-39.92B
PE Ratio
n/a
Profit Margin
-35.97%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.97B | -0.68% | 341,329 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.74B | -0.28% | 363,611 | 14.92B |
| 3 | ARGX | argenx SE | 48.73B | 0.66% | 102,973 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.08B | -2.95% | 462,955 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 32.69B | -0.38% | 59,247 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 29.59B | -2.38% | 1,627,812 | - |
| 7 | RPRX | Royalty Pharma plc | 29.23B | -1.56% | 993,298 | 2.38B |
| 8 | INSM | Insmed Incorporated | 29.13B | -1.00% | 752,486 | 606.42M |
| 9 | BNTX | BioNTech SE | 24.74B | -5.44% | 569,038 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.97B | -2.19% | 1,706,929 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.28B | 1.28% | 520,587 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 17.77B | -2.46% | 6,136,111 | 1.94B |
| 13 | GMAB | Genmab A/S | 16.28B | - | 512,124 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.82B | -2.50% | 160,666 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.48B | -2.22% | 741,078 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.77B | -23.30% | 13,629,659 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.51B | 1.22% | 602,222 | 1.06B |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.46B | -0.29% | 232,654 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.93B | 0.53% | 84,706 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.20B | -0.81% | 2,225,391 | 2.32B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 10.51B | -1.08% | 797,305 | 638.50M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.51B | 2.16% | 885,748 | 1.09B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.44B | 0.19% | 516,326 | 3.22B |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.12B | 2.74% | 178,583 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.96B | 1.29% | 250,232 | 5.37M |
| 26 | TECH | Bio-Techne Corporation | 8.68B | 0.23% | 711,866 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.20B | -0.79% | 210,793 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 8.08B | 1.69% | 1,088,221 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 7.82B | -0.79% | 190,815 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 7.79B | 0.87% | 111,647 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.58B | 0.44% | 348,705 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.35B | 0.28% | 4,195,341 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.62B | 0.09% | 317,608 | 51.48M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.30B | -0.32% | 89,181 | 46.02M |
| 35 | COGT | Cogent Biosciences, Inc. | 6.21B | 1.56% | 553,540 | - |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.15B | -4.31% | 685,888 | - |
| 37 | BLTE | Belite Bio, Inc | 6.14B | -1.99% | 57,878 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.12B | 0.44% | 463,365 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.01% | 1,456,897 | - |
| 40 | CELC | Celcuity Inc. | 6.09B | 3.75% | 1,165,897 | - |
| 41 | APGE | Apogee Therapeutics, Inc. | 6.05B | -1.17% | 135,451 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.92B | -0.27% | 199,384 | 521.31M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.67B | 2.13% | 297,668 | 189.76M |
| 44 | CGON | CG Oncology, Inc. | 5.59B | -0.88% | 271,343 | 4.04M |
| 45 | IMVT | Immunovant, Inc. | 5.55B | 0.46% | 445,641 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 5.54B | 2.23% | 768,939 | 7.50M |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.53B | -0.58% | 832,807 | - |
| 48 | PTCT | PTC Therapeutics, Inc. | 5.41B | 0.32% | 318,154 | 1.73B |
| 49 | CORT | Corcept Therapeutics Incorporated | 5.40B | 8.07% | 1,803,601 | 769.10M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.02% | 931,828 | 1.00B |
| 51 | CAI | Caris Life Sciences, Inc. | 5.24B | -2.42% | 1,238,303 | 812.03M |
| 52 | TGTX | TG Therapeutics, Inc. | 5.02B | 0.71% | 678,910 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.99B | -0.95% | 556,242 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.81B | 0.65% | 203,796 | 2.04M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.66B | 1.31% | 134,449 | 268.09M |
| 56 | LEGN | Legend Biotech Corporation | 4.35B | -0.09% | 529,230 | 1.03B |
| 57 | TVTX | Travere Therapeutics, Inc. | 4.10B | 5.41% | 780,369 | 490.73M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.09B | 0.80% | 445,506 | 7.70M |
| 59 | TLX | Telix Pharmaceuticals Limited | 3.79B | 2.50% | 105,370 | 803.79M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | -2.36% | 506,744 | 1.07B |
| 61 | MANE | Veradermics, Incorporated | 3.75B | 1.47% | 448,958 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.55B | -1.64% | 1,183,482 | - |
| 63 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.47B | 0.89% | 561,580 | 588.99M |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.31B | -0.65% | 214,358 | - |
| 65 | KLRA | Kailera Therapeutics, Inc. | 3.28B | 1.28% | 208,181 | - |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.25B | -1.12% | 322,138 | 22.50M |
| 67 | RCUS | Arcus Biosciences, Inc. | 3.19B | -0.27% | 391,189 | 247.00M |
| 68 | ORKA | Oruka Therapeutics, Inc. | 3.16B | -7.94% | 1,563,800 | - |
| 69 | ERAS | Erasca, Inc. | 3.16B | -4.60% | 5,692,221 | - |
| 70 | BEAM | Beam Therapeutics Inc. | 3.13B | 3.00% | 671,822 | 139.74M |
| 71 | ALMS | Alumis Inc. | 3.13B | -0.49% | 208,808 | 24.05M |
| 72 | TNGX | Tango Therapeutics, Inc. | 3.06B | -1.85% | 1,141,452 | 62.38M |
| 73 | GPCR | Structure Therapeutics Inc. | 2.99B | 1.64% | 851,989 | - |
| 74 | DNLI | Denali Therapeutics Inc. | 2.96B | -0.32% | 661,060 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.96B | 1.81% | 288,983 | 376.07M |
| 76 | NKTR | Nektar Therapeutics | 2.94B | 2.47% | 368,558 | 55.23M |
| 77 | DYN | Dyne Therapeutics, Inc. | 2.93B | 1.08% | 411,086 | - |
| 78 | KOD | Kodiak Sciences Inc. | 2.77B | 2.87% | 179,696 | - |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.09% | 539,813 | 190.41M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | 0.17% | 273,867 | 451.36M |
| 81 | IRON | Disc Medicine, Inc. | 2.55B | 1.45% | 158,453 | - |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.55B | -1.13% | 175,463 | 1.55M |
| 83 | IMNM | Immunome, Inc. | 2.54B | -2.05% | 463,658 | 6.94M |
| 84 | VERA | Vera Therapeutics, Inc. | 2.54B | -0.56% | 336,733 | - |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.51B | 1.92% | 265,418 | - |
| 86 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | -2.61% | 356,665 | 218.71M |
| 87 | ADMA | ADMA Biologics, Inc. | 2.44B | 2.63% | 1,723,168 | 510.17M |
| 88 | RLAY | Relay Therapeutics, Inc. | 2.44B | -0.46% | 1,611,441 | 15.36M |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.44B | 0.55% | 564,237 | 673.00M |
| 90 | ZLAB | Zai Lab Limited | 2.43B | -0.23% | 87,340 | 460.16M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | 8.93% | 1,148,615 | - |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | 2.78% | 1,092,237 | 2.20B |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.21B | 1.70% | 373,034 | 276.98M |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.19B | 0.18% | 806,628 | - |
| 95 | AAPG | Ascentage Pharma Group International | 2.10B | -1.42% | 224 | 82.08M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.06B | -0.37% | 263,144 | - |
| 97 | STOK | Stoke Therapeutics, Inc. | 2.06B | 1.02% | 187,958 | 184.42M |
| 98 | MESO | Mesoblast Limited | 2.05B | 1.15% | 97,160 | 65.38M |
| 99 | OCUL | Ocular Therapeutix, Inc. | 2.04B | - | 837,861 | 51.95M |
| 100 | ZYME | Zymeworks Inc. | 1.99B | -2.07% | 113,690 | 105.97M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98B | -0.75% | 615,072 | 283.06M |
| 102 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 1.38% | 416,250 | - |
| 103 | ANAB | AnaptysBio, Inc. | 1.92B | 1.54% | 152,630 | 234.60M |
| 104 | PHVS | Pharvaris N.V. | 1.90B | -6.42% | 195,128 | - |
| 105 | GLPG | Galapagos NV | 1.87B | 1.10% | 58,987 | 1.31B |
| 106 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | 0.08% | 568,681 | 9.77M |
| 107 | PVLA | Palvella Therapeutics, Inc. | 1.83B | -0.33% | 96,686 | - |
| 108 | CAPR | Capricor Therapeutics, Inc. | 1.83B | -5.75% | 920,364 | 11.13M |
| 109 | INBX | Inhibrx Biosciences, Inc. | 1.83B | -3.09% | 167,641 | 1.30M |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | 1.83B | 1.10% | 115,089 | 868.45M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | -0.72% | 8,056,244 | 74.68M |
| 112 | VCEL | Vericel Corporation | 1.79B | 1.40% | 116,559 | 276.26M |
| 113 | SION | Sionna Therapeutics, Inc. | 1.77B | 1.24% | 87,284 | - |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -6.91% | 2,495,622 | 217.17M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.75B | 1.26% | 301,092 | 71.78M |
| 116 | INVA | Innoviva, Inc. | 1.71B | 0.52% | 156,688 | 411.33M |
| 117 | ARDX | Ardelyx, Inc. | 1.67B | 7.27% | 7,702,169 | 427.68M |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | 0.75% | 517,088 | 66.05M |
| 119 | GENB | Generate Biomedicines, Inc. | 1.64B | 1.74% | 75,641 | 31.89M |
| 120 | NBTX | Nanobiotix S.A. | 1.63B | 1.10% | 62,248 | 38.27M |
| 121 | VIR | Vir Biotechnology, Inc. | 1.63B | -1.32% | 352,302 | 68.56M |
| 122 | OCS | Oculis Holding AG | 1.61B | -0.95% | 83,238 | 1.51M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.61B | 1.48% | 101,683 | - |
| 124 | NUVB | Nuvation Bio Inc. | 1.56B | 1.12% | 1,300,916 | 62.90M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -2.15% | 3,466,654 | 67.67M |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.54B | -0.74% | 138,080 | - |
| 127 | ATAI | AtaiBeckley Inc. | 1.52B | -0.72% | 1,213,339 | 4.09M |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -1.98% | 241,009 | 123.67M |
| 129 | MAZE | Maze Therapeutics, Inc. | 1.50B | 1.77% | 376,183 | 2.50M |
| 130 | BHVN | Biohaven Ltd. | 1.47B | 1.98% | 489,304 | - |
| 131 | IMTX | Immatics N.V. | 1.47B | -0.45% | 57,248 | 56.67M |
| 132 | MBX | MBX Biosciences, Inc. | 1.45B | 1.17% | 226,952 | - |
| 133 | IMCR | Immunocore Holdings plc | 1.45B | 2.47% | 395,896 | 400.02M |
| 134 | PGEN | Precigen, Inc. | 1.45B | -1.32% | 803,929 | 9.68M |
| 135 | IOVA | Iovance Biotherapeutics, Inc. | 1.42B | 2.68% | 5,842,930 | 263.50M |
| 136 | MPLT | MapLight Therapeutics, Inc. | 1.41B | -2.17% | 92,304 | - |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.41B | -0.05% | 100,489 | - |
| 138 | WVE | Wave Life Sciences Ltd. | 1.40B | 2.83% | 2,308,352 | 71.80M |
| 139 | VRDN | Viridian Therapeutics, Inc. | 1.37B | -1.26% | 424,066 | 70.85M |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | -0.04% | 3,346,387 | 73.62M |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -2.32% | 163,351 | - |
| 142 | ABCL | AbCellera Biologics Inc. | 1.33B | 5.78% | 3,877,909 | 75.13M |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.30B | 2.04% | 474,184 | - |
| 144 | NVAX | Novavax, Inc. | 1.30B | 0.44% | 1,867,661 | 1.12B |
| 145 | SVRA | Savara Inc. | 1.30B | -2.39% | 530,203 | - |
| 146 | GHRS | GH Research PLC | 1.27B | -0.10% | 69,439 | - |
| 147 | OLMA | Olema Pharmaceuticals, Inc. | 1.27B | 0.83% | 402,459 | - |
| 148 | DBVT | DBV Technologies S.A. | 1.26B | -3.62% | 97,173 | 5.64M |
| 149 | QURE | uniQure N.V. | 1.23B | -1.95% | 889,136 | 16.10M |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.20B | 25.39% | 3,146,140 | - |
| 151 | AVLN | Avalyn Pharma Inc. | 1.19B | -3.39% | 357,350 | - |
| 152 | MLTX | MoonLake Immunotherapeutics | 1.19B | 1.28% | 470,551 | - |
| 153 | COAG | Hemab Therapeutics Holdings, Inc. | 1.19B | 68.53% | 1,936,285 | - |
| 154 | PHAR | Pharming Group N.V. | 1.19B | -0.18% | 124 | 376.13M |
| 155 | JBIO | Jade Biosciences, Inc. | 1.18B | -2.17% | 222,733 | - |
| 156 | ZBIO | Zenas BioPharma, Inc. | 1.15B | 0.21% | 408,493 | 10.00M |
| 157 | EYPT | EyePoint, Inc. | 1.13B | 2.73% | 418,276 | 31.37M |
| 158 | FTRE | Fortrea Holdings Inc. | 1.13B | 5.04% | 517,047 | 2.72B |
| 159 | URGN | UroGen Pharma Ltd. | 1.12B | -3.19% | 342,799 | 109.79M |
| 160 | OMER | Omeros Corporation | 1.09B | 3.70% | 659,515 | - |
| 161 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | 2.20% | 803,226 | 291.85M |
| 162 | SEPN | Septerna, Inc. | 1.06B | -0.46% | 76,948 | 45.95M |
| 163 | IVA | Inventiva S.A. | 1.05B | -0.19% | 58,251 | 7.94M |
| 164 | AKTS | Aktis Oncology, Inc. | 1.04B | 0.56% | 160,468 | 6.50M |
| 165 | ORIC | ORIC Pharmaceuticals, Inc. | 1.00B | 1.32% | 302,349 | - |
| 166 | GERN | Geron Corporation | 1.00B | 1.62% | 6,644,161 | 183.88M |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 961.43M | 1.63% | 383,857 | 185.74M |
| 168 | ANNX | Annexon, Inc. | 949.04M | -0.51% | 481,813 | - |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 930.13M | 4.55% | 985,823 | 204.89M |
| 170 | XNCR | Xencor, Inc. | 926.27M | 5.87% | 261,401 | 125.58M |
| 171 | SLS | SELLAS Life Sciences Group, Inc. | 918.05M | 0.51% | 1,559,354 | - |
| 172 | CTMX | CytomX Therapeutics, Inc. | 912.14M | -0.71% | 1,629,978 | 76.20M |
| 173 | EVMN | Evommune, Inc. | 909.82M | 6.13% | 119,753 | 13.00M |
| 174 | LBRX | LB Pharmaceuticals Inc | 902.85M | -0.71% | 79,011 | - |
| 175 | SANA | Sana Biotechnology, Inc. | 885.57M | -0.30% | 858,310 | - |
| 176 | MNKD | MannKind Corporation | 881.61M | 0.88% | 1,351,889 | 348.97M |
| 177 | MGTX | MeiraGTx Holdings plc | 876.52M | 2.71% | 217,751 | 81.39M |
| 178 | JANX | Janux Therapeutics, Inc. | 871.11M | -0.35% | 264,401 | 10.00M |
| 179 | DRUG | Bright Minds Biosciences Inc. | 861.94M | -0.51% | 224,952 | - |
| 180 | TBPH | Theravance Biopharma, Inc. | 860.96M | -0.12% | 120,831 | 107.46M |
| 181 | ANRO | Alto Neuroscience, Inc. | 851.43M | -5.34% | 107,654 | - |
| 182 | ABUS | Arbutus Biopharma Corporation | 841.92M | 1.79% | 369,050 | 14.08M |
| 183 | DSGN | Design Therapeutics, Inc. | 841.61M | -0.92% | 181,804 | - |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 834.59M | 1.76% | 742,202 | 84.28M |
| 185 | CGEM | Cullinan Therapeutics, Inc. | 809.84M | 2.53% | 279,610 | - |
| 186 | SGP | SpyGlass Pharma, Inc. | 795.22M | 3.71% | 60,354 | - |
| 187 | RLMD | Relmada Therapeutics, Inc. | 790.86M | 0.27% | 582,549 | - |
| 188 | KURA | Kura Oncology, Inc. | 780.22M | -0.45% | 480,571 | 67.48M |
| 189 | TRAX | First Tracks Biotherapeutics, Inc. | 773.34M | -4.36% | 295,270 | - |
| 190 | ABSI | Absci Corporation | 771.02M | -0.30% | 1,664,246 | 2.80M |
| 191 | DRTS | Alpha Tau Medical Ltd. | 748.96M | 2.04% | 682,193 | - |
| 192 | TENX | Tenax Therapeutics, Inc. | 745.99M | -3.36% | 309,075 | - |
| 193 | VOR | Vor Biopharma Inc. | 742.34M | -4.40% | 293,311 | - |
| 194 | ALLO | Allogene Therapeutics, Inc. | 737.83M | 0.70% | 2,376,113 | 22.00K |
| 195 | GYRE | Gyre Therapeutics, Inc. | 714.99M | 1.95% | 54,785 | 116.59M |
| 196 | SLDB | Solid Biosciences Inc. | 703.65M | -1.52% | 380,983 | - |
| 197 | LXRX | Lexicon Pharmaceuticals, Inc. | 692.72M | 1.55% | 659,299 | 49.80M |
| 198 | ARVN | Arvinas, Inc. | 686.94M | 8.48% | 1,192,963 | 262.60M |
| 199 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 673.62M | 0.08% | 72,241 | - |
| 200 | FBRX | Forte Biosciences, Inc. | 663.60M | 1.69% | 94,986 | - |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 614.52M | 1.38% | 413,307 | 7.83M |
| 202 | CRMD | CorMedix Inc. | 607.82M | 2.11% | 301,874 | 311.71M |
| 203 | PRME | Prime Medicine, Inc. | 607.60M | -3.24% | 1,134,945 | 4.63M |
| 204 | OCGN | Ocugen, Inc. | 605.94M | 3.47% | 2,527,167 | 4.41M |
| 205 | ANL | Adlai Nortye Ltd. | 602.00M | 5.47% | 199,016 | 5.00M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 599.42M | -0.29% | 385,975 | 106.47M |
| 207 | CBIO | Crescent Biopharma, Inc. | 596.79M | -19.71% | 692,145 | 11.88M |
| 208 | PRTA | Prothena Corporation plc | 589.47M | -0.99% | 168,477 | 9.68M |
| 209 | STRO | Sutro Biopharma, Inc. | 586.50M | -3.33% | 126,764 | 102.48M |
| 210 | PROK | ProKidney Corp. | 576.75M | 0.53% | 240,369 | 893.00K |
| 211 | DNA | Ginkgo Bioworks Holdings, Inc. | 551.81M | 12.06% | 1,430,449 | 170.16M |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 542.20M | 1.52% | 85,543 | 294.28M |
| 213 | AGMB | AgomAb Therapeutics NV | 540.98M | 2.30% | 24,088 | - |
| 214 | TECX | Tectonic Therapeutic, Inc. | 537.67M | 2.38% | 45,324 | - |
| 215 | ALT | Altimmune, Inc. | 535.99M | 6.15% | 2,738,608 | 41.00K |
| 216 | KYTX | Kyverna Therapeutics, Inc. | 532.06M | -0.11% | 237,908 | - |
| 217 | MDXG | MiMedx Group, Inc. | 528.90M | 5.95% | 1,351,154 | 389.42M |
| 218 | STTK | Shattuck Labs, Inc. | 526.81M | -2.52% | 228,807 | 1.00M |
| 219 | TRDA | Entrada Therapeutics, Inc. | 519.55M | 5.33% | 100,283 | 25.42M |
| 220 | EIKN | Eikon Therapeutics, Inc. | 513.23M | -1.40% | 93,859 | - |
| 221 | VALN | Valneva SE | 510.85M | 0.74% | 11,729 | 205.07M |
| 222 | VSTM | Verastem, Inc. | 504.22M | 5.13% | 813,927 | 30.91M |
| 223 | UPB | Upstream Bio, Inc. | 500.12M | 0.11% | 174,443 | 2.85M |
| 224 | ENGN | enGene Therapeutics Inc. | 498.40M | 2.34% | 96,357 | - |
| 225 | ZURA | Zura Bio Limited | 496.23M | 2.95% | 175,550 | - |
| 226 | XOMA | XOMA Royalty Corporation | 491.52M | 0.76% | 284,996 | 52.15M |
| 227 | IMMX | Immix Biopharma, Inc. | 487.18M | 2.91% | 514,795 | - |
| 228 | FULC | Fulcrum Therapeutics, Inc. | 484.76M | 2.03% | 209,041 | 80.00M |
| 229 | LYEL | Lyell Immunopharma, Inc. | 484.06M | 5.17% | 26,786 | 36.00K |
| 230 | ADCT | ADC Therapeutics SA | 482.68M | 0.40% | 423,681 | 81.36M |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 481.19M | 2.12% | 175,936 | - |
| 232 | CTNM | Contineum Therapeutics, Inc. | 480.89M | 0.47% | 216,650 | - |
| 233 | PRLD | Prelude Therapeutics Incorporated | 480.64M | -8.60% | 777,117 | 12.14M |
| 234 | OVID | Ovid Therapeutics Inc. | 477.58M | -0.36% | 491,021 | 7.25M |
| 235 | RGNX | REGENXBIO Inc. | 475.65M | 2.73% | 301,830 | 170.44M |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 473.76M | 4.62% | 307,329 | 85.21M |
| 237 | SGMT | Sagimet Biosciences Inc. | 471.17M | -4.98% | 710,039 | - |
| 238 | CADL | Candel Therapeutics, Inc. | 465.85M | 2.91% | 913,321 | - |
| 239 | AURA | Aura Biosciences, Inc. | 457.10M | 0.99% | 83,304 | - |
| 240 | NMRA | Neumora Therapeutics, Inc. | 453.98M | 0.61% | 2,733,282 | - |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 443.38M | 1.00% | 69,451 | - |
| 242 | ASMB | Assembly Biosciences, Inc. | 433.55M | 1.22% | 21,369 | 72.30M |
| 243 | LXEO | Lexeo Therapeutics, Inc. | 427.48M | 1.32% | 211,444 | - |
| 244 | LRMR | Larimar Therapeutics, Inc. | 424.36M | 0.62% | 1,378,430 | - |
| 245 | IVVD | Invivyd, Inc. | 424.21M | 7.14% | 737,069 | 53.43M |
| 246 | VNDA | Vanda Pharmaceuticals Inc. | 423.35M | -0.85% | 357,357 | 216.11M |
| 247 | PRTC | PureTech Health plc | 421.78M | 7.54% | 25,045 | 4.66M |
| 248 | NGNE | Neurogene Inc. | 421.63M | 3.49% | 59,977 | 925.00K |
| 249 | CLYM | Climb Bio, Inc. | 419.65M | -1.07% | 854,163 | - |
| 250 | IPSC | Century Therapeutics, Inc. | 413.23M | 0.22% | 183,481 | 109.16M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 412.22M | 2.27% | 42,413 | 66.98M |
| 252 | BNTC | Benitec Biopharma Inc. | 408.32M | -1.08% | 31,586 | - |
| 253 | VTVT | vTv Therapeutics Inc. | 393.26M | -1.71% | 22,305 | 17.00K |
| 254 | AUTL | Autolus Therapeutics plc | 392.56M | 4.61% | 604,300 | 75.39M |
| 255 | NAGE | Niagen Bioscience, Inc. | 390.00M | 2.75% | 172,238 | 129.42M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 389.02M | 2.44% | 1,000,419 | - |
| 257 | SRZN | Surrozen, Inc. | 383.94M | 0.07% | 24,371 | 3.48M |
| 258 | PBYI | Puma Biotechnology, Inc. | 380.05M | -0.53% | 76,715 | 228.37M |
| 259 | LCTX | Lineage Cell Therapeutics, Inc. | 379.86M | 0.99% | 838,131 | 14.56M |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 375.50M | 1.47% | 114,207 | 35.11M |
| 261 | AVTX | Avalo Therapeutics, Inc. | 364.92M | 1.94% | 481,587 | 59.00K |
| 262 | IRD | Opus Genetics, Inc. | 360.94M | -1.08% | 298,651 | 14.20M |
| 263 | CMPX | Compass Therapeutics, Inc. | 350.27M | 9.89% | 6,767,334 | 850.00K |
| 264 | IMRX | Immuneering Corporation | 346.78M | 2.29% | 399,339 | - |
| 265 | MNPR | Monopar Therapeutics Inc. | 345.78M | -0.92% | 43,453 | - |
| 266 | GLSI | Greenwich LifeSciences, Inc. | 338.74M | 3.51% | 78,114 | - |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 337.93M | 1.52% | 136,457 | - |
| 268 | YDES | YD Bio Limited | 337.54M | -5.88% | 3,689 | 510.36K |
| 269 | BCYC | Bicycle Therapeutics plc | 337.38M | 2.54% | 247,170 | 63.50M |
| 270 | RZLT | Rezolute, Inc. | 335.51M | 0.94% | 863,840 | - |
| 271 | SLN | Silence Therapeutics plc | 334.89M | -3.01% | 33,866 | 559.00K |
| 272 | ARMP | Armata Pharmaceuticals, Inc. | 332.63M | -9.02% | 25,430 | 4.90M |
| 273 | PALI | Palisade Bio, Inc. | 331.50M | -1.00% | 2,134,737 | - |
| 274 | CABA | Cabaletta Bio, Inc. | 328.96M | -1.17% | 616,843 | - |
| 275 | DMAC | DiaMedica Therapeutics Inc. | 321.95M | -1.24% | 74,374 | - |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 321.30M | -0.26% | 565,360 | 1.00 |
| 277 | ABEO | Abeona Therapeutics Inc. | 311.15M | 0.18% | 431,611 | 5.82M |
| 278 | AVXL | Anavex Life Sciences Corp. | 306.74M | -0.90% | 250,754 | - |
| 279 | NGEN | NervGen Pharma Corp. | 301.06M | 2.48% | 27,346 | - |
| 280 | ACIU | AC Immune SA | 298.60M | -0.66% | 116,991 | 4.62M |
| 281 | TARA | Protara Therapeutics, Inc. | 288.81M | 0.19% | 216,665 | - |
| 282 | EDIT | Editas Medicine, Inc. | 286.28M | -2.50% | 527,413 | 40.52M |
| 283 | ZNTL | Zentalis Pharmaceuticals, Inc. | 286.21M | 0.62% | 426,419 | 26.87M |
| 284 | CLLS | Cellectis S.A. | 283.24M | 0.51% | 6,792 | 79.59M |
| 285 | CCCC | C4 Therapeutics, Inc. | 279.56M | 1.24% | 1,438,720 | 35.95M |
| 286 | FHTX | Foghorn Therapeutics Inc. | 279.41M | 0.21% | 40,057 | 30.91M |
| 287 | ELDN | Eledon Pharmaceuticals, Inc. | 279.18M | 0.96% | 788,784 | - |
| 288 | NBP | NovaBridge Biosciences | 278.13M | -2.63% | 1,203,639 | - |
| 289 | LENZ | LENZ Therapeutics, Inc. | 278.11M | -1.22% | 357,317 | 19.09M |
| 290 | CHRS | Coherus Oncology, Inc. | 275.28M | 0.56% | 342,085 | 42.17M |
| 291 | NERV | Minerva Neurosciences, Inc. | 274.01M | -3.40% | 29,504 | - |
| 292 | ALEC | Alector, Inc. | 261.56M | - | 174,855 | 21.05M |
| 293 | ARTV | Artiva Biotherapeutics, Inc. | 261.01M | 3.13% | 74,312 | 251.00K |
| 294 | HELP | Cybin Inc. | 257.68M | -3.01% | 409,929 | - |
| 295 | CGEN | Compugen Ltd. | 256.71M | 2.07% | 262,307 | 72.76M |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 254.98M | 5.35% | 9,270 | 19.39M |
| 297 | SABS | SAB Biotherapeutics, Inc. | 253.70M | -3.48% | 427,108 | 114.70K |
| 298 | ADAG | Adagene Inc. | 251.74M | 3.53% | 136,204 | 7.67M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 247.85M | 1.16% | 170,194 | 82.03M |
| 300 | CDXS | Codexis, Inc. | 247.16M | -3.55% | 489,422 | 70.39M |
| 301 | PLYX | Polaryx Therapeutics, Inc. | 241.90M | -2.68% | 31,559 | - |
| 302 | HRTX | Heron Therapeutics, Inc. | 240.51M | 6.25% | 1,707,009 | 154.90M |
| 303 | ALXO | ALX Oncology Holdings Inc. | 232.79M | 1.76% | 1,060,911 | - |
| 304 | OBIO | Orchestra BioMed Holdings, Inc. | 232.33M | -0.50% | 73,375 | 33.48M |
| 305 | MIST | Milestone Pharmaceuticals Inc. | 229.97M | 4.17% | 519,584 | 1.55M |
| 306 | ACHV | Achieve Life Sciences, Inc. | 228.13M | -2.39% | 226,851 | - |
| 307 | KROS | Keros Therapeutics, Inc. | 226.37M | 2.88% | 142,631 | 244.06M |
| 308 | NVCT | Nuvectis Pharma, Inc. | 226.24M | -0.23% | 19,728 | - |
| 309 | FENC | Fennec Pharmaceuticals Inc. | 225.81M | 0.92% | 64,667 | 44.64M |
| 310 | VYGR | Voyager Therapeutics, Inc. | 225.58M | 1.47% | 189,524 | 40.37M |
| 311 | CAMP | Camp4 Therapeutics Corporation | 216.01M | -0.24% | 53,973 | 3.50M |
| 312 | MDWD | MediWound Ltd. | 212.70M | 0.30% | 8,513 | 16.96M |
| 313 | CNTX | Context Therapeutics Inc. | 206.73M | -4.66% | 626,859 | - |
| 314 | RNA | Atrium Therapeutics, Inc. | 204.88M | 3.41% | 105,628 | 18.62M |
| 315 | NKTX | Nkarta, Inc. | 203.18M | 2.89% | 366,121 | - |
| 316 | OABI | OmniAb, Inc. | 201.25M | - | 126,777 | 18.67M |
| 317 | ELTX | Elicio Therapeutics, Inc. | 200.79M | 2.78% | 49,607 | - |
| 318 | MGNX | MacroGenics, Inc. | 199.26M | 1.79% | 159,230 | 149.50M |
| 319 | REPL | Replimune Group, Inc. | 198.59M | -6.42% | 1,633,261 | - |
| 320 | KRRO | Korro Bio, Inc. | 197.59M | 1.56% | 37,775 | 6.39M |
| 321 | ENLV | Enlivex Ltd. | 195.41M | 0.41% | 201,292 | - |
| 322 | UNCY | Unicycive Therapeutics, Inc. | 194.84M | 0.78% | 323,910 | - |
| 323 | OKUR | OnKure Therapeutics, Inc. | 193.49M | -9.11% | 134,835 | - |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 193.48M | 5.34% | 238,998 | 13.11M |
| 325 | KPTI | Karyopharm Therapeutics Inc. | 193.20M | 3.13% | 150,065 | 146.07M |
| 326 | DTIL | Precision BioSciences, Inc. | 186.56M | 1.12% | 171,319 | 34.26M |
| 327 | HUMA | Humacyte, Inc. | 186.50M | -0.21% | 1,392,947 | 2.04M |
| 328 | CNTN | Canton Strategic Holdings, Inc. | 181.02M | -1.08% | 222,124 | - |
| 329 | WHWK | Whitehawk Therapeutics, Inc. | 180.29M | -4.74% | 146,671 | 7.15M |
| 330 | CRBU | Caribou Biosciences, Inc. | 178.30M | -1.86% | 720,215 | 11.16M |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 175.06M | -0.10% | 232,867 | - |
| 332 | FATE | Fate Therapeutics, Inc. | 173.23M | 19.20% | 3,177,206 | 6.65M |
| 333 | MENS | Jyong Biotech Ltd. | 173.19M | -0.79% | 33,031 | - |
| 334 | ANTX | AN2 Therapeutics, Inc. | 172.78M | 5.49% | 72,234 | - |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 172.26M | -0.21% | 57,308 | - |
| 336 | PLX | Protalix BioTherapeutics, Inc. | 170.81M | -1.40% | 345,364 | 52.74M |
| 337 | TLSA | Tiziana Life Sciences Ltd | 169.10M | 3.52% | 26,613 | - |
| 338 | PRQR | ProQR Therapeutics N.V. | 165.94M | 0.32% | 245,122 | 19.19M |
| 339 | RNAC | Cartesian Therapeutics, Inc. | 164.75M | -0.08% | 140,075 | 1.78M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 159.36M | 1.55% | 62,130 | 2.00M |
| 341 | EDSA | Edesa Biotech, Inc. | 158.17M | -2.60% | 598,031 | - |
| 342 | SPRB | Spruce Biosciences, Inc. | 154.03M | -0.56% | 18,902 | 697.00K |
| 343 | MOLN | Molecular Partners AG | 153.58M | 8.98% | 164 | 856.30K |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 151.60M | 1.09% | 1,279,535 | - |
| 345 | ALPS | Alps Group Inc | 151.01M | 0.83% | 915 | 3.74M |
| 346 | HURA | TuHURA Biosciences, Inc. | 149.41M | 4.91% | 342,297 | - |
| 347 | KZIA | Kazia Therapeutics Limited | 148.66M | -4.62% | 128,938 | 1.27M |
| 348 | GALT | Galectin Therapeutics Inc. | 148.44M | -0.66% | 125,252 | - |
| 349 | AGEN | Agenus Inc. | 146.68M | -2.30% | 307,652 | 114.20M |
| 350 | BDTX | Black Diamond Therapeutics, Inc. | 146.37M | -3.58% | 480,454 | 70.00M |
| 351 | SPRO | Spero Therapeutics, Inc. | 145.02M | -0.20% | 355,739 | 66.80M |
| 352 | IFRX | InflaRx N.V. | 144.22M | -3.62% | 533,269 | 34.44K |
| 353 | CNTB | Connect Biopharma Holdings Limited | 138.48M | -0.81% | 19,738 | 64.00K |
| 354 | IPHA | Innate Pharma S.A. | 132.09M | 5.56% | 9,205 | 10.57M |
| 355 | EQ | Equillium, Inc. | 128.98M | - | 73,515 | 4.39M |
| 356 | IMUX | Immunic, Inc. | 128.25M | -1.98% | 106,802 | - |
| 357 | ACOG | Alpha Cognition Inc. | 126.29M | -2.85% | 15,584 | 10.22M |
| 358 | KLRS | Kalaris Therapeutics, Inc. | 126.11M | -0.36% | 59,302 | - |
| 359 | PEPG | PepGen Inc. | 120.26M | 6.10% | 1,331,088 | - |
| 360 | GNLX | Genelux Corporation | 119.36M | 0.75% | 76,173 | 8.00K |
| 361 | CRDF | Cardiff Oncology, Inc. | 117.25M | -0.87% | 214,400 | 593.00K |
| 362 | AARD | Aardvark Therapeutics, Inc. | 116.50M | -1.66% | 38,856 | - |
| 363 | CGTX | Cognition Therapeutics, Inc. | 114.82M | 1.98% | 729,462 | - |
| 364 | SEER | Seer, Inc. | 114.25M | 3.85% | 324,896 | 16.58M |
| 365 | VANI | Vivani Medical, Inc. | 113.44M | 0.01% | 48,782 | - |
| 366 | CUE | Cue Biopharma, Inc. | 112.64M | 134.74% | 16,719,658 | 27.47M |
| 367 | TTRX | Turn Therapeutics Inc. | 112.30M | 2.16% | 15,652 | - |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 109.09M | -0.31% | 9,719 | 35.58M |
| 369 | CBUS | Cibus, Inc. | 107.56M | 0.71% | 121,314 | 3.64M |
| 370 | GUTS | Fractyl Health, Inc. | 107.23M | 6.02% | 2,003,215 | 3.00K |
| 371 | PYXS | Pyxis Oncology, Inc. | 106.18M | -0.59% | 46,236 | 13.86M |
| 372 | ANIX | Anixa Biosciences, Inc. | 103.60M | 3.00% | 123,459 | - |
| 373 | ONCY | Oncolytics Biotech Inc. | 102.98M | 0.77% | 393,186 | - |
| 374 | NTHI | NeOnc Technologies Holdings, Inc. | 102.64M | -6.79% | 35,602 | 39.99K |
| 375 | NRXP | NRx Pharmaceuticals, Inc. | 101.58M | 3.19% | 324,646 | 1.23M |
| 376 | KALA | KALA BIO, Inc. | 99.92M | 2.28% | 2,361,431 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 99.22M | - | 93,781 | 7.95M |
| 378 | PMN | ProMIS Neurosciences, Inc. | 98.73M | -0.27% | 19,811 | - |
| 379 | BMEA | Biomea Fusion, Inc. | 97.97M | -0.37% | 725,181 | - |
| 380 | ALDX | Aldeyra Therapeutics, Inc. | 94.19M | 2.96% | 434,600 | - |
| 381 | RANI | Rani Therapeutics Holdings, Inc. | 93.27M | 5.25% | 477,152 | 1.63M |
| 382 | NRXS | NeurAxis, Inc. | 91.47M | 6.71% | 258,174 | 3.57M |
| 383 | INO | Inovio Pharmaceuticals, Inc. | 91.36M | -0.45% | 705,455 | 65.34K |
| 384 | OKYO | OKYO Pharma Limited | 87.64M | 7.05% | 85,375 | - |
| 385 | ACET | Adicet Bio, Inc. | 85.30M | 5.10% | 72,151 | - |
| 386 | PYPD | PolyPid Ltd. | 84.82M | -1.22% | 10,778 | - |
| 387 | ATYR | aTyr Pharma, Inc. | 84.52M | 6.76% | 1,035,180 | 190.00K |
| 388 | PTHS | Pelthos Therapeutics Inc. | 84.07M | 0.21% | 10,750 | 16.80M |
| 389 | CSBR | Champions Oncology, Inc. | 83.18M | 0.50% | 6,477 | 57.95M |
| 390 | EXOZ | eXoZymes, Inc. | 83.09M | -1.80% | 10,236 | -700.00 |
| 391 | GOSS | Gossamer Bio, Inc. | 83.04M | -3.81% | 1,336,575 | 48.47M |
| 392 | LONA | LeonaBio, Inc. | 81.63M | -4.51% | 19,648 | - |
| 393 | GANX | Gain Therapeutics, Inc. | 80.68M | 1.06% | 312,519 | - |
| 394 | MAIA | MAIA Biotechnology, Inc. | 79.78M | -1.13% | 412,702 | - |
| 395 | ICCC | ImmuCell Corporation | 78.98M | 3.19% | 13,568 | 27.64M |
| 396 | ATHE | Alterity Therapeutics Limited | 78.15M | 4.41% | 26,838 | 4.43M |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 77.88M | 8.65% | 602,263 | - |
| 398 | XBIT | XBiotech Inc. | 77.44M | -1.16% | 6,619 | - |
| 399 | QTTB | Q32 Bio Inc. | 77.24M | -5.71% | 157,388 | 53.74M |
| 400 | FLNA | Filana Therapeutics, Inc. | 75.84M | 8.28% | 572,018 | - |
| 401 | FBIO | Fortress Biotech, Inc. | 75.84M | 2.39% | 169,751 | 63.26M |
| 402 | PLRX | Pliant Therapeutics, Inc. | 75.23M | -0.41% | 188,260 | - |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 73.33M | -1.08% | 101,874 | - |
| 404 | TCRX | TScan Therapeutics, Inc. | 73.02M | 4.74% | 362,242 | 10.33M |
| 405 | ESLA | Estrella Immunopharma, Inc. | 72.53M | 3.66% | 91,393 | - |
| 406 | MCRB | Seres Therapeutics, Inc. | 72.33M | 2.37% | 11,627 | 789.00K |
| 407 | IBO | Impact BioMedical Inc. | 71.56M | -2.40% | 45,092 | 32.00K |
| 408 | ACTU | Actuate Therapeutics, Inc. | 70.19M | 0.68% | 71,076 | - |
| 409 | MNOV | MediciNova, Inc. | 69.89M | 2.16% | 5,907 | 409.66K |
| 410 | OSTX | OS Therapies Incorporated | 68.73M | -3.82% | 404,094 | - |
| 411 | ANVS | Annovis Bio, Inc. | 68.20M | 0.25% | 443,776 | - |
| 412 | IMA | ImageneBio, Inc. | 65.66M | -2.49% | 40,091 | 800.00K |
| 413 | IMMP | Immutep Limited | 64.60M | -5.29% | 1,294,317 | 5.28M |
| 414 | BYSI | BeyondSpring Inc. | 62.91M | 0.64% | 4,884 | 1.88M |
| 415 | CING | Cingulate Inc. | 61.63M | 2.91% | 244,511 | - |
| 416 | HYFT | MindWalk Holdings Corp. | 58.85M | -0.42% | 69,827 | 20.70M |
| 417 | IBIO | iBio, Inc. | 57.83M | -5.33% | 436,687 | 300.00K |
| 418 | INKT | MiNK Therapeutics, Inc. | 57.36M | -5.33% | 11,814 | - |
| 419 | TIL | Instil Bio, Inc. | 54.87M | 1.38% | 5,889 | - |
| 420 | KZR | Kezar Life Sciences, Inc. | 54.15M | 0.27% | 10,264 | - |
| 421 | PDSB | PDS Biotechnology Corporation | 54.12M | -0.34% | 198,751 | - |
| 422 | ENTX | Entera Bio Ltd. | 52.68M | -5.04% | 197,874 | 42.00K |
| 423 | SGMO | Sangamo Therapeutics, Inc. | 52.41M | 6.12% | 12,500,238 | 39.55M |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 51.92M | - | 67,762 | 25.21M |
| 425 | DWTX | Dogwood Therapeutics, Inc. | 49.60M | 3.85% | 31,192 | - |
| 426 | XLO | Xilio Therapeutics, Inc. | 48.98M | 6.94% | 29,750 | 43.77M |
| 427 | RLYB | Rallybio Corporation | 48.72M | 2.56% | 36,029 | 858.00K |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 48.48M | 0.71% | 120,844 | - |
| 429 | RADX | Radiopharm Theranostics Limited | 48.39M | 2.81% | 18,844 | 10.86M |
| 430 | NTRB | Nutriband Inc. | 47.48M | 1.06% | 2,206 | 2.04M |
| 431 | HYPD | Hyperion DeFi, Inc. | 46.59M | 1.37% | 114,290 | 813.46K |
| 432 | ATOS | Atossa Therapeutics, Inc. | 45.18M | -2.29% | 24,985 | - |
| 433 | MREO | Mereo BioPharma Group plc | 43.10M | 0.60% | 589,361 | 500.00K |
| 434 | PSTV | Plus Therapeutics, Inc. | 41.82M | -0.73% | 60,795 | 5.21M |
| 435 | LITS | Lite Strategy, Inc. | 41.45M | -0.87% | 91,944 | - |
| 436 | RNXT | RenovoRx, Inc. | 40.57M | 5.93% | 324,974 | 1.12M |
| 437 | PTN | Palatin Technologies, Inc. | 39.98M | 3.27% | 10,109 | 8.96M |
| 438 | INMB | INmune Bio Inc. | 39.35M | 3.50% | 67,782 | 50.00K |
| 439 | ATRA | Atara Biotherapeutics, Inc. | 39.25M | 0.63% | 22,655 | 120.77M |
| 440 | LIXT | Lixte Biotechnology Holdings, Inc. | 38.91M | -4.31% | 4,172 | - |
| 441 | ALGS | Aligos Therapeutics, Inc. | 38.30M | 3.34% | 167,480 | 2.19M |
| 442 | EVAX | Evaxion A/S | 37.95M | 3.17% | 23,532 | 7.53M |
| 443 | GRCE | Grace Therapeutics, Inc. | 36.98M | 6.70% | 622,385 | - |
| 444 | VERU | Veru Inc. | 36.51M | 1.11% | 33,100 | 16.89M |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 35.38M | 2.25% | 82,598 | 90.00K |
| 446 | CRVO | CervoMed Inc. | 35.09M | 2.71% | 34,870 | 4.01M |
| 447 | DARE | Daré Bioscience, Inc. | 35.09M | 5.70% | 293,418 | 1.03M |
| 448 | APLM | Apollomics, Inc. | 35.06M | 22.81% | 3,676 | 8.84M |
| 449 | HOWL | Werewolf Therapeutics, Inc. | 34.99M | 0.06% | 60,287 | 1.14M |
| 450 | PLUR | Pluri Inc. | 34.98M | -0.03% | 348 | 1.34M |
| 451 | SNSE | Sensei Biotherapeutics, Inc. | 34.86M | -2.29% | 15,115 | - |
| 452 | NXTC | NextCure, Inc. | 34.54M | 5.32% | 63,029 | - |
| 453 | BOLD | Boundless Bio, Inc. | 33.95M | 3.77% | 31,386 | - |
| 454 | QNTM | Quantum BioPharma Ltd. | 33.40M | -2.79% | 299,124 | - |
| 455 | IGC | IGC Pharma, Inc. | 33.22M | 5.19% | 924,230 | 1.11M |
| 456 | NRSN | NeuroSense Therapeutics Ltd. | 31.81M | 9.61% | 103,190 | - |
| 457 | PLRZ | Polyrizon Ltd. | 30.89M | 3.77% | 40,386 | - |
| 458 | SNTI | Senti Biosciences Holdings, Inc. | 30.83M | 7.04% | 183,504 | 22.00K |
| 459 | BCTX | BriaCell Therapeutics Corp. | 30.36M | -0.96% | 73,094 | - |
| 460 | TPST | Tempest Therapeutics, Inc. | 29.19M | 2.26% | 82,897 | - |
| 461 | DYAI | Dyadic International, Inc. | 29.17M | 2.04% | 15,390 | 3.09M |
| 462 | TVRD | Tvardi Therapeutics, Inc. | 28.99M | -1.90% | 11,216 | - |
| 463 | KYNB | Kyntra Bio, Inc. | 28.82M | -2.04% | 2,342 | 6.44M |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 28.57M | 0.57% | 7,626 | 14.99M |
| 465 | LSTA | Lisata Therapeutics, Inc. | 28.45M | 0.96% | 5,889 | 170.00K |
| 466 | RNTX | Rein Therapeutics Inc. | 28.32M | -25.46% | 8,263,213 | - |
| 467 | SKYE | Skye Bioscience, Inc. | 28.10M | -8.98% | 274,234 | - |
| 468 | NNVC | NanoViricides, Inc. | 27.86M | 4.03% | 235,046 | - |
| 469 | CELU | Celularity Inc. | 27.50M | 2.05% | 39,050 | 40.58M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 26.53M | 1.25% | 159,650 | - |
| 471 | TVGN | Tevogen Bio Holdings Inc. | 26.36M | -4.67% | 4,703 | - |
| 472 | OTLK | Outlook Therapeutics, Inc. | 26.32M | 0.64% | 1,734,294 | 205.70K |
| 473 | BRNS | Barinthus Biotherapeutics plc | 25.73M | -3.08% | 3,286 | 14.97M |
| 474 | ABVC | ABVC BioPharma, Inc. | 25.70M | 0.97% | 8,402 | 797.92K |
| 475 | LGVN | Longeveron Inc. | 24.91M | 0.02% | 131,419 | 1.20M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 24.81M | 2.09% | 342,855 | 789.00K |
| 477 | MRKR | Marker Therapeutics, Inc. | 24.34M | - | 27,729 | 3.55M |
| 478 | CRIS | Curis, Inc. | 24.00M | 0.07% | 58,115 | 9.44M |
| 479 | AEON | AEON Biopharma, Inc. | 23.28M | -0.33% | 56,336 | - |
| 480 | LTRN | Lantern Pharma Inc. | 23.26M | 1.22% | 166,281 | - |
| 481 | SER | Serina Therapeutics, Inc. | 22.23M | -0.82% | 19,197 | 130.00K |
| 482 | OSRH | OSR Holdings, Inc. | 21.46M | -7.82% | 11,473,888 | 2.91M |
| 483 | VYNE | VYNE Therapeutics Inc. | 21.38M | 0.77% | 84,534 | 570.00K |
| 484 | QNCX | Quince Therapeutics, Inc. | 21.35M | - | 371,038 | - |
| 485 | XCUR | Exicure, Inc. | 21.00M | -1.93% | 10,623 | 500.00K |
| 486 | ALLR | Allarity Therapeutics, Inc. | 20.55M | -3.78% | 122,893 | 320.00K |
| 487 | CVKD | Cadrenal Therapeutics, Inc. | 19.61M | -4.50% | 103,026 | - |
| 488 | KTTA | Pasithea Therapeutics Corp. | 19.28M | 11.30% | 1,062,171 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 19.16M | -2.80% | 118,039 | - |
| 490 | LPCN | Lipocine Inc. | 18.94M | 1.29% | 50,727 | 1.98M |
| 491 | CVM | CEL-SCI Corporation | 18.69M | -24.76% | 571,293 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 17.99M | 8.82% | 91,415 | 1.23M |
| 493 | LEXX | Lexaria Bioscience Corp. | 17.57M | 7.59% | 69,557 | 368.00K |
| 494 | GNTA | Genenta Science S.p.A. | 17.22M | 2.63% | 19,456 | - |
| 495 | TOVX | Theriva Biologics, Inc. | 16.91M | 2.77% | 2,302,645 | - |
| 496 | NCEL | NewcelX Ltd. | 16.91M | -15.87% | 27,745 | - |
| 497 | PASG | Passage Bio, Inc. | 16.43M | 0.21% | 18,186 | - |
| 498 | TRAW | Traws Pharma, Inc. | 15.24M | 4.90% | 133,464 | 2.79M |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 15.00M | -3.69% | 583,352 | 3.94M |
| 500 | JUNS | Jupiter Neurosciences, Inc. | 14.91M | 8.39% | 47,349 | 21.80K |